On July 14, 2025, the Food and Drug Administration (FDA or Agency) held a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032.
Similar Posts
Ashfiat Alharamain Energy Support may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Ashfiat Alharamain Energy Support, a product promoted and sold for male sexual enhancement on various websites, including Amazon.com (Akkarco, LLC storefront), and possibly in some retail stores.Amish Origins Management, LLC – 704166 – 05/29/2025
CGMP/Finished Pharmaceuticals/AdulteratedCountry Eggs, LLC Recalls Large Brown Cage Free “Sunshine Yolks” Because of Possible Health Risk
Country Eggs, LLC of Lucerne Valley, CA is recalling our LARGE BROWN CAGE FREE SUNSHINE YOLKS because it has the potential to be contaminated with Salmonella, an organism which
can cause serious and sometimes fatal infections in young children, frail or elderly people and others with weakened immunWegmans Recalls Locatelli Grated Pecorino Romano Cheese Due to Possible Health Risk
Wegmans Food Markets is recalling Locatelli Grated Pecorino Romano Cheese with Wegmans’ scale labels due to the potential presence of Listeria monocytogenes, an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immuneEducational Resources
Educational ResourcesIntercos Europe S.p.A – 682273 – 08/15/2024
CGMP/Finished Pharmaceuticals/Adulterated